Submitted by Anonymous (not verified) on 17 March 2026 - 15:39
Human medicines European public assessment report (EPAR): Daybu, trofinetide, Status: Opinion under re-examination
Source:
Human medicines European public assessment report (EPAR): Daybu, trofinetide, Status: Opinion under re-examination